Judith A Aberg, MD

img_Judith A Aberg
PROFESSOR EMERITUS | Medicine, Infectious Diseases
Publications

Selected Publications

Effect of Pitavastatin on Epigenetic Aging Biomarkers in People With HIV: Pilot Substudy of the REPRIEVE Trial. Michael J. Corley, Maya Watanabe, Alina P.S. Pang, Varun B. Dwaraka, Ryan Smith, Wadzanai Samaneka, Sarah Henn, Sonal Munsiff, Maria Saumoy, Sara McCallum, Kathleen V. Fitch, Sarah M. Chu, Marissa R. Diggs, Judith A. Aberg, Carlos D. Malvestutto, Carl J. Fichtenbaum, Judith S. Currier, Markella V. Zanni, Pamela S. Douglas, Michael T. Lu, Alan L. Landay, Kristine M. Erlandson, Heather J. Ribaudo, Steven K. Grinspoon. Clinical Infectious Diseases

Factors Affecting Risk of Cardiovascular Disease (CVD) Events in a Global CVD Prevention Cohort of People with HIV. Steven K. Grinspoon, Maya Watanabe, Heather J. Ribaudo, Gerald S. Bloomfield, Carl J. Fichtenbaum, Triin Umbleja, Sarah M. Chu, Kathleen V. Fitch, Marissa R. Diggs, Sophia Zhao, Sara E. Looby, Judith S. Currier, Judith A. Aberg, Carlos D. Malvestutto, Kristine M. Erlandson, Esteban Martinez, Olabimpe Asupoto, Samir K. Gupta, Juan C. Lopez-Bernaldo De Quiros, Daniel Nixon, Roger Bedimo, Michael T. Lu, Pamela S. Douglas, Markella V. Zanni. Clinical Infectious Diseases

Phase 1 trial of intranasal NDV-HXP-S in previously vaccinated adults. Sean T.H. Liu, Irene González-Domínguez, Amparo Martínez-Pérez, Cansu Cimen Bozkus, Oscar Bladh, Tarashon Broomes-Pennicott, Alina Jen, Elizabeth Egan, Edna Leiva-Ortiz, Ashley Abid, Katherina Aguilera, Mikael Åberg, Disha Bhavsar, Temima Yellin, Anass Abbad, Gagandeep Singh, Juan Manuel Carreño, Joshua Adams, Christina Quigley, Mansi Saxena, Marcia Meseck, Ilaria Ceglia, Charlotte Thålin, Daniela Weiskopf, Adolfo García-Sastre, Peter Palese, Weina Sun, Florian Krammer, Judith A. Aberg. Vaccine

View All Publications

Assessing Cardiovascular Risk for Persons with HIV Infection

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Aberg during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Glaxosmithkline
  • Merck Sharp & Dohme Corp

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.